Post-Election Markets Pricing to Shift to Vaccine Progress and Growth Outlook – Goldman

Post-Election Markets Pricing to Shift to Vaccine Progress and Growth Outlook – Goldman

Goldman strategists believe that the financial markets have moved a long way towards pricing in the U.S. election outcome, according to Bloomberg. The strategist points out that attention is now on vaccine progress in light of the worsening pandemic. Global stocks are also weighing on Joe Biden’s presidency, and higher optimism could raise prices despite Donald Trump’s refusal to concede. 

  • Goldman expects major stock indexes to rise and Cboe Volatility Index to drop to reflect news of an early, safe, and effective vaccine.
  • There is likely dollar weakness, tighter credit spreads, and higher treasury yields following early vaccine news.
  • Analysts predict Canadian and Australian dollars to benefit most in foreign exchange markets.
  • Current asset prices reflect a probability of slightly more than 50% for early vaccine and significant delays could lead to downside risks-Goldman

Global stocks are mixed as the dollar weakens against the Euro, amidst falling volatility. S&P 500 is slightly down 0.029%, QQQ: NASDAQ is up 0.75%, DAX is up 2.05%, CAC 40 is up 1.72%, EURUSD is up 0.08%,VIX is down 10.77%

Our Experts


Daniel Michelson

Daniel is a long term investor and position trader in the forex market.

Reva Green

Reva Green is the Senior Editor for website. An experienced media professional, Reva has close to a decade of editorial experience with a background.

Shandor Brenner

Shandor Brenner, an experienced writer at fxaudit.com, brings a wealth of knowledge with over 20 years in the investment field.

Leave a Reply

CAPTCHA ImageChange Image